Acute Effects of Tolvaptan on Renal Hemodynamics in Autosomal Dominant Polycystic Kidney Disease —A Randomized, Cross-Over, Double Blind, Placebo-Controlled Study of Renal Plasma Flow and Glomerular Filtration Rate

Autor: rgen Jensen, June Anita Ejlersen, Rikke Lund S oslash, nderbæk, rgaard Bech, Frank H Mose, Jesper N oslash, Erling B. Pedersen, My Helbo Malmberg, Jens J oslash

Publikováno v: Malmberg, M H, Mose, F H, Sønderbæk, R L, Ejlersen, J A, Jensen, J J, Pedersen, E B & Bech, J N 2019, ' Acute Effects of Tolvaptan on Renal Hemodynamics in Autosomal Dominant Polycystic Kidney Disease : A Randomized, Cross-Over, Double Blind, Placebo-Controlled Study of Renal Plasma Flow and Glomerular Filtration Rate ', Open Journal of Nephrology, vol. 9, no. 4, pp. 97-114 . https://doi.org/10.4236/ojneph.2019.94011

Background: Previous studies have shown that reduced renal plasma flow (RPF) may play a role in progression of renal disease in autosomal dominant polycystic kidney disease (ADPKD). Tolvaptan, a vasopressin 2 antagonist, reduces growth of total kidne

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::541bf90ba1d1eada99a4b5e536ee123f
https://doi.org/10.4236/ojneph.2019.94011